Satipharm is a health & wellbeing company that specializes in the development and manufacture of cannabinoid-based products from the cannabis plant. The Satipharm manufacturing process is in line with the international standards of Good Manufacturing Practice (GMP). This allows Satipharm to provide products of high quality, that are manufactured in a regulated, safe environment.
Satipharm is owned by Harvest One, a global company that develops and distributes premium health, wellness and self-care products with a market focus on sleep, pain, and anxiety. Harvest One owns and operates three subsidiaries; Satipharm, Dream Water Global, and Delivra; as well as a controlling interest in Greenbelt Greenhouse.
United Greeneries, Harvest One's cultivation arm, is a Canadian Licensed Producer under the Cannabis Act. United Greeneries has two main facilities, the Duncan Facility on Vancouver Island in BC and the Lucky Lake Facility in Saskatchewan.
United Greeneries develops premium products for both the recreation and medical markets. Their Royal High brand is available in limited quantities from time to time from Medical Cannabis by Shoppers.